Kinaxis (TSE:KXS) Given New C$210.00 Price Target at National Bank Financial

Kinaxis (TSE:KXSGet Free Report) had its price objective raised by investment analysts at National Bank Financial from C$200.00 to C$210.00 in a note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bank Financial’s price target would suggest a potential upside of 20.59% from the company’s previous close.

Several other analysts also recently commented on KXS. Stifel Nicolaus reduced their price objective on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating for the company in a research report on Wednesday, May 6th. Royal Bank Of Canada increased their target price on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a research note on Friday, May 8th. Canadian Imperial Bank of Commerce raised their price target on shares of Kinaxis from C$173.00 to C$205.00 in a report on Friday, June 5th. Finally, BMO Capital Markets lifted their price target on shares of Kinaxis from C$180.00 to C$185.00 in a research note on Friday, May 8th. Seven investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Kinaxis currently has an average rating of “Buy” and an average price target of C$203.12.

Get Our Latest Report on Kinaxis

Kinaxis Trading Up 2.5%

Shares of TSE:KXS traded up C$4.19 during midday trading on Friday, reaching C$174.15. The company’s stock had a trading volume of 85,293 shares, compared to its average volume of 122,823. Kinaxis has a fifty-two week low of C$117.22 and a fifty-two week high of C$204.85. The company has a debt-to-equity ratio of 12.15, a quick ratio of 2.29 and a current ratio of 1.72. The firm has a 50 day moving average price of C$157.76 and a two-hundred day moving average price of C$144.97. The firm has a market capitalization of C$4.76 billion, a price-to-earnings ratio of 59.23, a PEG ratio of 3.60 and a beta of 0.76.

Kinaxis (TSE:KXSGet Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$1.08 EPS for the quarter. Kinaxis had a return on equity of 19.72% and a net margin of 14.48%.The business had revenue of C$230.64 million during the quarter. As a group, analysts forecast that Kinaxis will post 4.2526231 earnings per share for the current year.

Insider Activity at Kinaxis

In other news, Director Robert G. Courteau sold 5,010 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the transaction, the director directly owned 32,945 shares of the company’s stock, valued at C$4,987,543.55. This represents a 13.20% decrease in their ownership of the stock. Also, insider Conrad John Mandala sold 924 shares of the stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of C$137.14, for a total value of C$126,717.36. Following the completion of the transaction, the insider owned 820 shares in the company, valued at approximately C$112,454.80. This represents a 52.98% decrease in their ownership of the stock. In the last 90 days, insiders have sold 35,934 shares of company stock valued at $5,328,181. Corporate insiders own 1.20% of the company’s stock.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.